Table of Contents
Patchouli has spent decades earning a reputation as the scent of joss sticks and 1970s nostalgia, the kind of smell that clings to vintage clothing shops and makes certain people leave the room. It turns out this was doing it a disservice. The rich, earthy aroma that makes patchouli so polarising in perfume also makes it, apparently, rather good at confusing mosquitoes. A team of researchers at Brazil’s Federal University of Amapá has managed to turn this botanical oddity into a lotion that performs as well as DEET, the synthetic repellent that has dominated bug sprays since the US military developed it in the 1940s.
Aedes aegypti, the mosquito responsible for dengue, Zika, chikungunya and yellow fever, kills hundreds of thousands of people every year. Personal repellents are one of the few defences ordinary people can actually use, and DEET is by far the most effective option available. But it carries a whiff (a rather different kind) of controversy: some studies have flagged concerns about skin irritation and neurotoxicity in children, and it is not exactly biodegradable. The search for something that works nearly as well, but sits more easily on sensitive skin and in waterways, has been going on for decades without producing anything close to a mainstream rival.
Plant-derived oils have attracted the most attention. Citronella, lemon eucalyptus, lavender: the list of candidates tested is long and the results are, frankly, unimpressive. Most essential oils repel mosquitoes reasonably well for perhaps twenty or thirty minutes before evaporating away, far short of the three or four hours DEET can manage. The volatility problem is fundamental. An oil that disperses quickly into the air will protect you when you first apply it and not much after. Lizandra Lima Santos and her colleagues at Amapá decided the solution might be formulation rather than chemistry: find an oil with genuine repellent activity and engineer the lotion so it stays on the skin long enough to matter.
A Plant With Hidden Complexity
Patchouli was not an obvious choice. Its reputation rests on fragrance, not pharmacology. But Santos’s group had been studying the chemical complexity of Pogostemon cablin, the South Asian plant that produces patchouli oil, for some time. Gas chromatography analysis of oil collected from plants grown near Macapá, in the Brazilian Amazon, identified 16 compounds, with patchouli alcohol as the dominant constituent at roughly 40 percent. Several of the remaining sesquiterpenes, particularly alpha-guaiene and beta-elemene, showed up in computer modelling as potentially interesting.
The modelling work is perhaps the most mechanistically revealing part of this study. Mosquitoes find hosts by detecting chemical signals through olfactory receptor proteins, and one of these proteins, known as AaegOBP1, acts essentially as a molecular delivery system, ferrying scent molecules towards sensory neurons. DEET works partly by binding to this protein and blocking the recognition pathway. When Santos’s team docked their patchouli compounds computationally against the same binding site, they found that alpha-guaiene bound with an affinity differing from DEET by less than 0.001 kcal/mol, a margin so small it is, for practical purposes, indistinguishable. Beta-elemene performed similarly. The inference is that patchouli oil may work, at the molecular level, through something close to the same mechanism as the synthetic it is being asked to replace.
“Unlike many natural repellents that lose effectiveness quickly due to volatility, our formulation achieved complete protection against Aedes aegypti for up to three hours at a relatively low concentration of patchouli oil,” says Lima Santos.
Arm in a Cage
Getting to that result required solving the formulation problem. The team incorporated the oil into a standard oil-in-water cream base at a concentration of 200 ppm, adding it at around 40 degrees Celsius during production, late enough in the process to minimise evaporative loss. The resulting cream was stable across 90 days of testing under various storage conditions, keeping its consistency at both refrigerator temperatures and 45 degrees without phase separation or significant pH drift.
Volunteers applied either the experimental cream or a commercial DEET formulation to their forearms and inserted their arms into cages containing fifty hungry female mosquitoes. The untreated control arm attracted bites throughout. Arms treated with the patchouli cream attracted none, for the full three hours of testing, matching DEET bite-for-bite. Santos noted that natural repellents are typically expected to require higher concentrations to match synthetic compounds’ performance, which made achieving complete protection for three hours at such a low dose particularly striking.
There are caveats. Several patchouli oil constituents, including patchouli alcohol itself, triggered skin irritation alerts in computational toxicology modelling, and the carcinogenicity predictions are, by the researchers’ own description, preliminary. None of the compounds showed mutagenicity in Ames test predictions, and the concentrations involved are low, but formal clinical and toxicological trials have not yet been done. The arm-in-cage test is a controlled laboratory setup rather than a swampy riverbank, and real-world performance involves variables including sweat, humidity and the particular behavioural repertoire of local mosquito populations, which the cage experiment does not capture.
None of which undermines the basic finding, only contextualises it. There is a meaningful difference between showing something works in a cage study and showing it is ready to sit next to sunscreen on a pharmacy shelf. Santos’s team acknowledge as much, with plans for targeted toxicological and clinical work to follow.
What makes this more than a neat chemistry result is the scale of the problem it is attempting to address. Arboviral diseases are expanding their geographic range as temperatures rise. Vector control, meaning reducing mosquito populations rather than just biting rates, is hamstrung by insecticide resistance and the logistical difficulty of reaching remote communities. Personal repellents fill a gap, but only if people actually use them; formulations that smell of industrial chemicals or require expensive synthesis are a harder sell than something derived from a plant already cultivated across South and Southeast Asia for its fragrance. If the clinical data supports what the cage data suggests, patchouli might yet find a second career.
https://doi.org/10.1021/acsomega.6c00802
Frequently Asked Questions
Why doesn’t citronella work as well as DEET if it’s also a plant-based repellent?
The core problem with citronella and most other essential oils is volatility: they evaporate from skin within twenty to thirty minutes, which is far shorter than the three or four hours DEET remains active. The patchouli team addressed this not by finding a less volatile oil, but by engineering a cream formulation that retains the active compounds on the skin surface long enough to matter. Whether that approach could work with citronella too is an open question.
How does a repellent actually stop mosquitoes from finding you?
Mosquitoes locate hosts by detecting chemical signals, particularly carbon dioxide and skin odours, through olfactory receptor proteins in their antennae. DEET appears to work partly by binding to one of these proteins, called AaegOBP1, and disrupting the signal. The patchouli oil compounds alpha-guaiene and beta-elemene showed binding affinities to the same protein that were essentially identical to DEET’s in computer modelling, suggesting the plant oil may interfere with the same detection pathway rather than simply masking your scent.
Is patchouli oil actually safe to put on your skin?
At the concentrations tested (200 parts per million in cream), the preliminary safety profile looks reasonable, but the researchers are candid about what is not yet known. Computational modelling flagged potential skin irritation alerts for patchouli alcohol, the oil’s main constituent, and some compounds showed hepatotoxicity signals under systemic exposure scenarios. None showed mutagenicity. Formal clinical trials have not been done, and the researchers are calling for targeted toxicological studies before the formulation could move towards commercial use.
Could a natural repellent actually replace DEET in high-risk areas?
Not on current evidence, but the results from this study are more competitive than anything produced by previous natural alternatives. The three-hour complete protection time matches DEET’s performance in the same test conditions, which no other botanical formulation has managed at such a low concentration. The bigger challenge is probably regulatory and clinical: moving from a cage bioassay in a university lab to a product safe for use on children in dengue-endemic regions requires considerably more data than this study provides, however promising the early numbers look.
Quick Note Before You Read On.
ScienceBlog.com has no paywalls, no sponsored content, and no agenda beyond getting the science right. Every story here is written to inform, not to impress an advertiser or push a point of view.
Good science journalism takes time — reading the papers, checking the claims, finding researchers who can put findings in context. We do that work because we think it matters.
If you find this site useful, consider supporting it with a donation. Even a few dollars a month helps keep the coverage independent and free for everyone.
